Generation of kidney cancer-specific antitumor immune responses using peripheral blood monocytes transduced with a recombinant adenovirus encoding carbonic anhydrase 9.
D000256:Adenoviridae / Q000235:genetics*; D015153:Blotting, Western; D019496:Cancer Vaccines; D002256:Carbonic Anhydrases / Q000235:genetics*; D002292:Carcinoma, Renal Cell / Q000276:immunology* / Q000628:therapy*; D002448:Cell Adhesion; D045744:Cell Line, Tumor; D003001:Cloning, Molecular; D016207:Cytokines / Q000378:metabolism; D005434:Flow Cytometry; D005822:Genetic Vectors; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000276:immunology* / Q000628:therapy*; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D008858:Microscopy, Phase-Contrast; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism; D010641:Phenotype; D013601:T-Lymphocytes / Q000378:metabolism
D019496:Cancer Vaccines; D016207:Cytokines; D002256:Carbonic Anhydrases